 |
BioWorld-International-2006-10-11
Pfizer Moving Into Vaccines With PowderMed Acquisition
Faust Brings in €8M Bridge Financing, Aims For More
No Abstract
BioWorld International Correspondent
PARIS - Faust Pharmaceuticals, which is developing therapies for nervous system diseases, completed an €8.2 million insider bridge financing, which is intended to be the first tranche of a €25 million C round funding.
Pfizer Moving Into Vaccines With PowderMed Acquisition
LONDON - Pfizer Inc. made a strategic advance into vaccines, acquiring DNA vaccines specialist PowderMed Ltd. The value of the deal, which includes a needle-free delivery system and a portfolio of products, was not disclosed. (BioWorld International)